{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T20:05:49Z","timestamp":1785269149454,"version":"3.55.0"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.lfs.2022.120346","type":"journal-article","created":{"date-parts":[[2022,1,20]],"date-time":"2022-01-20T02:12:50Z","timestamp":1642644770000},"page":"120346","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Reconnoitering the transformative journey of minocycline from an antibiotic to an antiepileptic drug"],"prefix":"10.1016","volume":"293","author":[{"given":"Tanveer","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surabhi","family":"Thapliyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiveena","family":"Bhatia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varinder","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manjinder","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasandeep","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Awanish","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2022.120346_bb0005","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.3389\/fphar.2019.01008","article-title":"Neuroinflammation as a common feature of neurodegenerative disorders","volume":"10","author":"Guzman-Martinez","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.lfs.2022.120346_bb0010","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1592\/phco.26.4.515","article-title":"Minocycline for short-term neuroprotection","volume":"26","author":"Elewa","year":"2006","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.lfs.2022.120346_bb0015","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.eplepsyres.2015.01.001","article-title":"Progress report on new antiepileptic drugs: a summary of the Twelfth Eilat Conference (EILAT XII)","volume":"111","author":"Bialer","year":"2015","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.lfs.2022.120346_bb0020","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/epi.13634","article-title":"Progress report on new antiepileptic drugs: a summary of the Thirteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XIII)","volume":"58","author":"Bialer","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.lfs.2022.120346_bb0025","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.phrs.2012.10.006","article-title":"What is behind the non-antibiotic properties of minocycline?","volume":"67","author":"Garrido-Mesa","year":"2013","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.lfs.2022.120346_bb0030","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/bph.12139","article-title":"Minocycline: far beyond an antibiotic","volume":"169","author":"Garrido-Mesa","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.lfs.2022.120346_bb0035","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.yebeh.2012.03.035","article-title":"Minocycline- and tetracycline-class antibiotics are protective against partial seizures in vivo","volume":"24","author":"Wang","year":"2012","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.lfs.2022.120346_bb0040","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1139\/cjpp-2017-0673","article-title":"Anticonvulsant effect of minocycline on pentylenetetrazole-induced seizure in mice: involvement of nitric oxide and N-methyl-d-aspartate receptor","volume":"96","author":"Amini-Khoei","year":"2018","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.lfs.2022.120346_bb0045","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.neuroscience.2013.04.058","article-title":"Long-lasting effects of minocycline on behavior in young but not adult fragile X mice","volume":"246","author":"Dansie","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.lfs.2022.120346_bb0050","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1007\/s13365-011-0050-5","article-title":"Once initiated, viral encephalitis-induced seizures are consistent no matter the treatment or lack of interleukin-6","volume":"17","author":"Libbey","year":"2011","journal-title":"J. Neurovirol."},{"key":"10.1016\/j.lfs.2022.120346_bb0055","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1111\/epi.13577","article-title":"Acute treatment with minocycline, but not valproic acid, improves long-term behavioral outcomes in the Theiler's virus model of temporal lobe epilepsy","volume":"57","author":"Barker-Haliski","year":"2016","journal-title":"Epilepsia"},{"key":"10.1016\/j.lfs.2022.120346_bb0060","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1128\/JVI.02747-12","article-title":"Infiltrating macrophages are key to the development of seizures following virus infection","volume":"87","author":"Cusick","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.lfs.2022.120346_bb0065","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1111\/epi.16715","article-title":"Neocortical injury\u2013induced status epilepticus","volume":"61","author":"Singh","year":"2020","journal-title":"Epilepsia"},{"key":"10.1016\/j.lfs.2022.120346_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2019.07.027","article-title":"Neurobiology of organophosphate-induced seizures","volume":"101","author":"Williamson","year":"2019","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.lfs.2022.120346_bb0075","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1124\/pr.110.003046","article-title":"Prevention or modification of epileptogenesis after brain insults: experimental approaches and translational research","volume":"62","author":"L\u00f6scher","year":"2010","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.lfs.2022.120346_bb0080","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s10072-013-1552-0","article-title":"Effect of minocycline on pentylenetetrazol-induced chemical kindled seizures in mice","volume":"35","author":"Ahmadirad","year":"2014","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.lfs.2022.120346_bb0085","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/j.pharep.2016.07.005","article-title":"Neuroprotective mechanism of coenzyme Q10 (CoQ10) against PTZ induced kindling and associated cognitive dysfunction: possible role of microglia inhibition","volume":"68","author":"Bhardwaj","year":"2016","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.lfs.2022.120346_bb0090","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.seizure.2013.05.005","article-title":"The effect of minocycline on seizures induced by amygdala kindling in rats","volume":"22","author":"Beheshti Nasr","year":"2013","journal-title":"Seizure"},{"key":"10.1016\/j.lfs.2022.120346_bb0095","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.nbd.2012.02.006","article-title":"Minocycline attenuates microglia activation and blocks the long-term epileptogenic effects of early-life seizures","volume":"46","author":"Abraham","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.lfs.2022.120346_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2021.113317","article-title":"Rapamycin, but not minocycline, significantly alters ultrasonic vocalization behavior in C57BL\/6J pups in a flurothyl seizure model","volume":"410","author":"Hodges","year":"2021","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.lfs.2022.120346_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2020.134953","article-title":"Dexamethasone after early-life seizures attenuates increased susceptibility to seizures, seizure-induced microglia activation and neuronal injury later in life","volume":"728","author":"Fox","year":"2020","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.lfs.2022.120346_bb0110","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.neuroscience.2014.12.021","article-title":"Minocycline inhibits brain inflammation and attenuates spontaneous recurrent seizures following pilocarpine-induced status epilepticus","volume":"287","author":"Wang","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.lfs.2022.120346_bb0115","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1007\/s13311-020-00834-5","article-title":"TSPO PET identifies different anti-inflammatory minocycline treatment response in two rodent models of epileptogenesis","volume":"17","author":"Wolf","year":"2020","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.lfs.2022.120346_bb0120","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/NRL.0b013e31822aad04","article-title":"Refractory epilepsy associated with microglial activation","volume":"17","author":"Najjar","year":"2011","journal-title":"Neurologist"},{"key":"10.1016\/j.lfs.2022.120346_bb0125","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.neulet.2006.01.027","article-title":"Minocycline inhibits caspase-dependent and -independent cell death pathways and is neuroprotective against hippocampal damage after treatment with kainic acid in mice","volume":"398","author":"Heo","year":"2006","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.lfs.2022.120346_bb0130","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1111\/epi.14190","article-title":"Lamotrigine-resistant corneal-kindled mice: a model of pharmacoresistant partial epilepsy for moderate-throughput drug discovery","volume":"59","author":"Koneval","year":"2018","journal-title":"Epilepsia"},{"key":"10.1016\/j.lfs.2022.120346_bb0135","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ejphar.2016.05.019","article-title":"Adjuvant indoleamine 2,3-dioxygenase enzyme inhibition for comprehensive management of epilepsy and comorbid depression","volume":"784","author":"Singh","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.lfs.2022.120346_bb0140","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1742-2094-11-41","article-title":"Activation of brain indoleamine 2,3-dioxygenase contributes to epilepsy-associated depressive-like behavior in rats with chronic temporal lobe epilepsy","volume":"11","author":"Xie","year":"2014","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.lfs.2022.120346_bb0145","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/jnr.22224","article-title":"Roles of astrocytes and microglia in seizure-induced aberrant neurogenesis in the hippocampus of adult rats","volume":"88","author":"Yang","year":"2009","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.lfs.2022.120346_bb0150","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.yebeh.2012.12.015","article-title":"Neonatal immune challenge exacerbates seizure-induced hippocampus-dependent memory impairment in adult rats","volume":"27","author":"Yin","year":"2013","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.lfs.2022.120346_bb0155","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1002\/glia.23018","article-title":"Microglia engulf viable newborn cells in the epileptic dentate gyrus","volume":"64","author":"Luo","year":"2016","journal-title":"Glia"},{"key":"10.1016\/j.lfs.2022.120346_bb0160","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1111\/epi.13429","article-title":"Microglial activation during epileptogenesis in a mouse model of tuberous sclerosis complex","volume":"57","author":"Zhang","year":"2016","journal-title":"Epilepsia"},{"key":"10.1016\/j.lfs.2022.120346_bb0165","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.neuroscience.2017.03.012","article-title":"Inhibition of microglial activation with minocycline at the intrathecal level attenuates sympathoexcitatory and proarrhythmogenic changes in rats with chronic temporal lobe epilepsy","volume":"350","author":"Bhandare","year":"2017","journal-title":"Neuroscience"},{"key":"10.1016\/j.lfs.2022.120346_bb0170","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1212\/01.WNL.0000133403.30559.FF","article-title":"Minocycline safety and tolerability in Huntington disease","volume":"63","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.lfs.2022.120346_bb0175","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1093\/brain\/aws072","article-title":"Results of a phase II placebo-controlled randomized trial of minocycline in acute spinal cord injury","volume":"135","author":"Casha","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.lfs.2022.120346_bb0180","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S1474-4422(07)70270-3","article-title":"Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial","volume":"6","author":"Gordon","year":"2007","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.lfs.2022.120346_bb0185","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1093\/rheumatology\/40.3.329","article-title":"Minocycline-induced lupus: clinical features and response to rechallenge","volume":"40","author":"Lawson","year":"2001","journal-title":"Rheumatology"},{"key":"10.1016\/j.lfs.2022.120346_bb0190","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.eplepsyres.2013.09.006","article-title":"Minocycline exerts acute inhibitory effects on cerebral cortex excitability in humans","volume":"107","author":"Lang","year":"2013","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.lfs.2022.120346_bb0195","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/DBP.0b013e318287cd17","article-title":"A randomized double-blind, placebo-controlled trial of minocycline in children and adolescents with fragile X syndrome","volume":"34","author":"Leigh","year":"2013","journal-title":"J. Dev. Behav. Pediatr."},{"key":"10.1016\/j.lfs.2022.120346_bb0200","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/1471-2377-10-91","article-title":"Open-label add-on treatment trial of minocycline in fragile X syndrome","volume":"10","author":"Paribello","year":"2010","journal-title":"BMC Neurol."},{"key":"10.1016\/j.lfs.2022.120346_bb0205","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.seizure.2011.12.009","article-title":"Minocycline as potent anticonvulsant in a patient with astrocytoma and drug resistant epilepsy","volume":"21","author":"Nowak","year":"2012","journal-title":"Seizure"},{"key":"10.1016\/j.lfs.2022.120346_bb0210","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1080\/02699052.2019.1566968","article-title":"Safety and feasibility of minocycline in treatment of acute traumatic brain injury","volume":"33","author":"Meythaler","year":"2019","journal-title":"Brain Inj."},{"key":"10.1016\/j.lfs.2022.120346_bb0215","doi-asserted-by":"crossref","first-page":"13","DOI":"10.4161\/oxim.3.1.10028","article-title":"Clinical physiology and mechanism of dizocilpine (MK-801): electron transfer, radicals, redox metabolites and bioactivity","volume":"2","author":"Kovacic","year":"2010","journal-title":"Oxid. Med. Cell.Longev."},{"key":"10.1016\/j.lfs.2022.120346_bb0220","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.yebeh.2016.05.005","article-title":"Evidence in support of using a neurochemistry approach to identify therapy for both epilepsy and associated depression","volume":"61","author":"Singh","year":"2016","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.lfs.2022.120346_bb0225","first-page":"2336","article-title":"Parallel pathways of seizure generalization","volume":"142","author":"Dabrowska","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.lfs.2022.120346_bb0230","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.pharep.2016.10.001","article-title":"Adjuvant neuronal nitric oxide synthase inhibition for combined treatment of epilepsy and comorbid depression","volume":"69","author":"Singh","year":"2017","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.lfs.2022.120346_bb0235","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.neuint.2016.12.023","article-title":"Adjuvant quercetin therapy for combined treatment of epilepsy and comorbid depression","volume":"104","author":"Singh","year":"2017","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.lfs.2022.120346_bb0240","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.biopha.2017.05.085","article-title":"Agmatine for combined treatment of epilepsy, depression and cognitive impairment in chronic epileptic animals","volume":"92","author":"Singh","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.lfs.2022.120346_bb0245","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1007\/s11064-017-2325-6","article-title":"Ferulic acid supplementation for management of depression in epilepsy","volume":"42","author":"Singh","year":"2017","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.lfs.2022.120346_bb0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11064-021-03257-6","article-title":"A review on potential footprints of ferulic acid for treatment of neurological disorders","volume":"46","author":"Thapliyal","year":"2021","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.lfs.2022.120346_bb0255","article-title":"Anticonvulsant effect of Asparagus racemosus willd. in a mouse model of catamenial epilepsy","author":"Pahwa","year":"2021","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.lfs.2022.120346_bb0260","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.3390\/biology10111097","article-title":"Recent developments in diagnosis of epilepsy: scope of microrna and technological advancements","volume":"10","author":"Bandopadhyay","year":"2021","journal-title":"Biology"},{"key":"10.1016\/j.lfs.2022.120346_bb0265","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.ajhg.2016.10.002","article-title":"Mechanistic insight into NMDA receptor dysregulation by rare variants in the GluN2A and GluN2B agonist binding domains","volume":"99","author":"Swanger","year":"2016","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.lfs.2022.120346_bb0270","doi-asserted-by":"crossref","DOI":"10.1177\/1179069518810423","article-title":"Unique biology and single-channel properties of GluN2A-and GluN2C-containing triheteromeric N-methyl-D-aspartate receptors","volume":"12","author":"Bhattacharya","year":"2018","journal-title":"J. Exp. Neurosci."},{"key":"10.1016\/j.lfs.2022.120346_bb0275","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.neuron.2018.06.010","article-title":"Triheteromeric GluN1\/GluN2A\/GluN2C NMDARs with unique single-channel properties are the dominant receptor population in cerebellar granule cells","volume":"99","author":"Bhattacharya","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.lfs.2022.120346_bb0280","doi-asserted-by":"crossref","first-page":"5495","DOI":"10.1113\/JP278168","article-title":"Functional and pharmacological properties of triheteromeric GluN1\/2B\/2D NMDA receptors","volume":"597","author":"Yi","year":"2019","journal-title":"J. Physiol."},{"key":"10.1016\/j.lfs.2022.120346_bb0285","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.nbd.2010.04.001","article-title":"Microglial ablation, and lipopolysaccharide preconditioning affects pilocarpine-induced seizures in mice","volume":"39","author":"Mirrione","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.lfs.2022.120346_bb0290","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jneuroim.2015.11.003","article-title":"Lipopolysaccharide preconditioning prevents acceleration of kindling epileptogenesis induced by traumatic brain injury","volume":"289","author":"Eslami","year":"2015","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.lfs.2022.120346_bb0295","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.4058-14.2015","article-title":"Antagonism of PACAP or microglia function worsens the cardiovascular consequences of kainic-acid-induced seizures in rats","volume":"35","author":"Bhandare","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.lfs.2022.120346_bb0300","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1523\/JNEUROSCI.2584-15.2016","article-title":"Seizure-induced sympathoexcitation is caused by activation of glutamatergic receptors in RVLM that also causes proarrhythmogenic changes mediated by PACAP and microglia in rats","volume":"36","author":"Bhandare","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.lfs.2022.120346_bb0305","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1159\/000113733","article-title":"Feasibility of minocycline and doxycycline use as potential vasculostatic therapy for brain vascular malformations: pilot study of adverse events and tolerance","volume":"25","author":"Frenzel","year":"2008","journal-title":"Cerebrovasc. Dis."},{"key":"10.1016\/j.lfs.2022.120346_bb0310","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12883-014-0232-x","article-title":"An open-label pilot trial of minocycline in children as a treatment for Angelman syndrome","volume":"14","author":"Grieco","year":"2014","journal-title":"BMC Neurol."},{"key":"10.1016\/j.lfs.2022.120346_bb0315","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1007\/s11064-021-03274-5","article-title":"Epilepsy associated depression: an update on current scenario, suggested mechanisms, and opportunities","volume":"46","author":"Singh","year":"2021","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.lfs.2022.120346_bb0320","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.yebeh.2016.10.007","article-title":"Managing epilepsy-associated depression: serotonin enhancers or serotonin producers?","volume":"66","author":"Singh","year":"2017","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.lfs.2022.120346_bb0325","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1007\/s11011-021-00823-3","article-title":"PTZ kindling model for epileptogenesis, refractory epilepsy, and associated comorbidities: relevance and reliability","volume":"36","author":"Singh","year":"2021","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.lfs.2022.120346_bb0330","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.yebeh.2017.04.004","article-title":"Neurochemical evidence based suggested therapy for safe management of epileptogenesis","volume":"72","author":"Kaur","year":"2017","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.lfs.2022.120346_bb0335","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-016-0773-6","article-title":"Pro-epileptogenic effects of viral-like inflammation in both mature and immature brains","volume":"13","author":"Dupuis","year":"2016","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.lfs.2022.120346_bb0340","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.nbd.2009.07.025","article-title":"Viral-like brain inflammation during development causes increased seizure susceptibility in adult rats","volume":"36","author":"Galic","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.lfs.2022.120346_bb0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2019.172446","article-title":"Protective effect of minocycline on LPS-induced mitochondrial dysfunction and decreased seizure threshold through nitric oxide pathway","volume":"858","author":"Haj-Mirzaian","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.lfs.2022.120346_bb0350","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1742-2094-10-30","article-title":"Neuroprotective and antiepileptogenic effects of combination of anti-inflammatory drugs in the immature brain","volume":"10","author":"Kwon","year":"2013","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.lfs.2022.120346_bb0355","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1089\/neu.2011.2114","article-title":"Aquaporin-4 reduces post-traumatic seizure susceptibility by promoting astrocytic glial scar formation in mice","volume":"38","author":"Lu","year":"2021","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.lfs.2022.120346_bb0360","doi-asserted-by":"crossref","first-page":"17151","DOI":"10.1073\/pnas.0806682105","article-title":"Microglial activation and TNF\u03b1 production mediate altered CNS excitability following peripheral inflammation","volume":"105","author":"Riazi","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.lfs.2022.120346_bb0365","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ejphar.2015.12.002","article-title":"Minocycline fails to exert antiepileptogenic effects in a rat status epilepticus model","volume":"771","author":"Russmann","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.lfs.2022.120346_bb0370","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.lfs.2006.02.027","article-title":"Effects of second generation tetracyclines on penicillin-epilepsy-induced hippocampal neuronal loss and motor incoordination in rats","volume":"79","author":"Yilmaz","year":"2006","journal-title":"Life Sci."},{"key":"10.1016\/j.lfs.2022.120346_bb0375","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-018-1260-z","article-title":"Metalloprotease Adam10 suppresses epilepsy through repression of hippocampal neuroinflammation","volume":"15","author":"Zhu","year":"2018","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.lfs.2022.120346_bb0380","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1002\/glia.23876","article-title":"Seizure progression triggered by IQSEC3 loss is mitigated by reducing activated microglia in mice","volume":"68","author":"Park","year":"2020","journal-title":"Glia"},{"key":"10.1016\/j.lfs.2022.120346_bb0385","doi-asserted-by":"crossref","first-page":"5377","DOI":"10.1523\/JNEUROSCI.0089-19.2019","article-title":"Context-specific switch from anti-to pro-epileptogenic function of the P2Y1 receptor in experimental epilepsy","volume":"39","author":"Alves","year":"2019","journal-title":"J. Neurosci."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320522000467?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320522000467?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T20:53:54Z","timestamp":1758401634000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320522000467"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":77,"alternative-id":["S0024320522000467"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2022.120346","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reconnoitering the transformative journey of minocycline from an antibiotic to an antiepileptic drug","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2022.120346","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"120346"}}